NCT06847061 Pulmonary Rehabilitation for Rural Patients With COPD
| NCT ID | NCT06847061 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Chronic Obstructive Pulmonary Disease (COPD |
| Study Type | INTERVENTIONAL |
| Enrollment | 306 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2029-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 306 participants in total. It began in 2025-04-01 with a primary completion date of 2029-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to test the uptake, effectiveness, and patient-caregiver-provider experience of a crucial treatment not provided in rural areas: pulmonary rehabilitation.
Eligibility Criteria
Inclusion Criteria * 40 years of age or older * Physician-diagnosed COPD * Living in a rural area defined by Rural-Urban Commuting Area Codes 4-10 * mMRC score\>=1 * English Speaking Exclusion Criteria * Inability to walk (orthopedic/neurologic/cardiac limitation causing immobility) * Cognitive impairment or inability to understand and follow instructions. * Patients with no COPD symptom burden, no breathlessness (mMRC score 0), as based on our previous studies they usually perceive no benefit from PR and do not have compliance with PR. * Traditional center-based PR was completed within 3 months of initial study recruitment. * Transition to hospice or end-of-life care at the time of screening. * Acute exacerbation at the time of screening.
Contact & Investigator
Roberto Benzo, M.D.
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT06847061 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Chronic Obstructive Pulmonary Disease (COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06847061 currently recruiting?
Yes, NCT06847061 is actively recruiting participants. Contact the research team at Hoult.Johanna@mayo.edu for enrollment information.
Where is the NCT06847061 trial being conducted?
This trial is being conducted at Scottsdale, United States, Rochester, United States.
Who is sponsoring the NCT06847061 clinical trial?
NCT06847061 is sponsored by Mayo Clinic. The principal investigator is Roberto Benzo, M.D. at Mayo Clinic. The trial plans to enroll 306 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.